Swiss biotech CMC meeting

Tuesday, September 1, 2026, 12:00 - 18:30

Swiss Data Science Center - SDSC, Biopôle, Rte de la Corniche 8, 1066 Epalinges

Join us at our informal peer-to-peer meeting for chemistry, manufacturing and quality control specialists across the Swiss biotech ecosystem — from startups to established companies — from preclinical, clinical and commercial settings. Whether you are a chief technical officer, chief operating officer, head of CMC, or a quality or supply chain leader, we will discuss how to translate scientific innovation into robust, compliant and scalable manufacturing solutions.

Experienced industry leaders who have successfully navigated some of biotech’s most challenging CMC and operational hurdles will share practical insights, lessons learned and real-world experiences — helping to avoid common pitfalls and accelerate development timelines.

Together, we will address key topics and explore how to manage cost and timeline pressures while ensuring manufacturing readiness, quality and compliance across all stages of development.

We are looking forward to an afternoon of knowledge sharing, networking and practical discussion focused on one of the most critical success factors in biotechnology: successful CMC execution.

Your input and presence will help make this event a success. We welcome you to share your ideas to help shape the final program as you register below.

Know a CMC leader who should join?
Please share the contact details of any CMC peers (full name, organization, email, function) whom you believe we should also invite. Alternatively, you may forward the invitation to them directly. If your organization does not have a dedicated CMC specialist, you are kindly invited to register yourself.

Kindly supported by

siegfried-logo

Preliminary program

More program details and speakers will be announced in due course…

12:00 – 13:30

Doors open, light lunch

13:30

Welcome, opening remarks & introduction

  • Michael Altorfer, CEO Swiss Biotech Association
  • Anne Marie de Jonge Schuermans, Board Member Swiss Biotech Association & Global Head Biologics & Injectables Operations, Sandoz
  • Short address by sponsor Siegfried

13:40 – 15:00

Keynote address

15:00

Coffee break

15:30 – 16:10

Success stories of CMC readiness in Swiss biotech startups

16:10 – 17:00

Panel discussion with active audience participation and moderated by

  • Anne Marie de Jonge Schuermans, Global Head Biologics & Injectables Operations, Sandoz
  • Sonja Merkas, Founder and CEO, Livinovea

Confirmed speakers & panelists

  • Stefan Abele, Chief Technical Operations, Pharvaris
  • Marc Thommen, former Head of Technical Development and Operations at TargImmune Therapeutics
  • Keith Wilson, Chief Technology Officer, Switchkine

Register